J 2007

TSPY gene copy number as a potential new risk factor for male infertility

VODICKA, R., R. VRTEL, Ladislav DUŠEK, A.R. SINGH, K. KRIZOVA et. al.

Základní údaje

Originální název

TSPY gene copy number as a potential new risk factor for male infertility

Název česky

TSPY gene copy number as a potential new risk factor for male infertility

Autoři

VODICKA, R. (203 Česká republika), R. VRTEL (203 Česká republika), Ladislav DUŠEK (203 Česká republika, garant), A.R. SINGH (203 Česká republika), K. KRIZOVA (203 Česká republika), V. SVACINOVA (203 Česká republika), V. HORINOVA (203 Česká republika), J. DOSTAL (203 Česká republika), I. OBORNA (203 Česká republika), J. BREZINOVA (203 Česká republika), A. SOBEK (203 Česká republika) a J. SANTAVY (203 Česká republika)

Vydání

Reproductive Biomedicine Online, 2007, 1472-6491

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30214 Obstetrics and gynaecology

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.840

Kód RIV

RIV/00216224:14110/07:00040020

Organizační jednotka

Lékařská fakulta

UT WoS

000246445000009

Klíčová slova anglicky

capillary electrophoresis; male infertility; multicopy gene; quantitative fluorescence PCR; TSPY gene; Y chromosome
Změněno: 1. 4. 2010 08:44, prof. RNDr. Ladislav Dušek, Ph.D.

Anotace

V originále

The human TSPY (testis-specific protein, Y-linked) gene family (30-60 copies) is situated in the MSY (male-specific) region of the Y chromosome. Testis-specific expression indicates that the gene plays a role in spermatogenesis. Refined quantitative fluorescence PCR (polymerase chain reaction) was applied to evaluate the relative number of TSPY copies compared with AMELY/X (amelogenin gene, Y-linked) genes in 84 stratified infertile men and in 40 controls. A significantly higher number of TSPY copies was found in infertile men compared with the controls (P = 0.002). The diagnostic discrimination potential of the relative number of TSPY copies was evaluated by receiver operating characteristic curve analysis. TSPY/AMELY was unambiguously found to be powerful in the diagnostic separation of both the control samples and the infertile men, reaching a good level of specificity (0.642) and sensitivity (0.732) at a cut-off point of 0.46. The findings were supported by independently repeated studies of randomly selected positive samples and controls. Evaluation of the TSPY copy number offers a completely new diagnostic approach in relation to the genetic cause of male infertility. The possible effect of the copy number of TSPY genes on spermatogenesis may explain indiscrete pathological alterations of spermatid quality and quantity.

Česky

The human TSPY (testis-specific protein, Y-linked) gene family (30-60 copies) is situated in the MSY (male-specific) region of the Y chromosome. Testis-specific expression indicates that the gene plays a role in spermatogenesis. Refined quantitative fluorescence PCR (polymerase chain reaction) was applied to evaluate the relative number of TSPY copies compared with AMELY/X (amelogenin gene, Y-linked) genes in 84 stratified infertile men and in 40 controls. A significantly higher number of TSPY copies was found in infertile men compared with the controls (P = 0.002). The diagnostic discrimination potential of the relative number of TSPY copies was evaluated by receiver operating characteristic curve analysis. TSPY/AMELY was unambiguously found to be powerful in the diagnostic separation of both the control samples and the infertile men, reaching a good level of specificity (0.642) and sensitivity (0.732) at a cut-off point of 0.46. The findings were supported by independently repeated studies of randomly selected positive samples and controls. Evaluation of the TSPY copy number offers a completely new diagnostic approach in relation to the genetic cause of male infertility. The possible effect of the copy number of TSPY genes on spermatogenesis may explain indiscrete pathological alterations of spermatid quality and quantity.

Návaznosti

NR8442, projekt VaV
Název: Standardizace a individualizace léčby testikulárních germinálních nádorů (příprava centralizace veškeré péče do dvou center v ČR)
Investor: Ministerstvo zdravotnictví ČR, Standardizace a individualizace léčby testikulárních germinálních nádorů (příprava centralizace veškeré péče do dvou center v ČR